Discover and read the best of Twitter Threads about #SIUJ

Most recents (4)

In last month’s issue of #SIUJ, @JessicaDeLong23 and @RamonVirasoro discuss the development of a GURS fellowship and training program in the Caribbean bit.ly/3tliRIb #OpenAccess #urology #urosome

(1/n)
With over 5 billion people lacking access to adequate surgical and anesthesia care across the globe, the global health community is focusing on reducing these health inequalities by improving access and overall outcomes.

(2/n)
During annual mission trips to Dominican Republic (DR), the authors recognized a need for more Urological Reconstructive Surgery trained physicians within the community. This need inspired the creation of a GURS in the DR.

(3/n)
Read 8 tweets
In this #SIUJ editorial, @pcvblack discussed gender disparity in urology. Why is this a priority for @SIU_Journal and what barriers remain in place?

Read full article: siuj.org/index.php/siuj…
#OpenAccess

(1/n)
Gender disparity is a big problem that deserves a lot more attention within the urological community. The ultimate goal of gender equality is to develop a diverse urologic workforce that provides optimal patient care. (2/n)
We need to attract more women into training and more female urologists into leadership roles. Providing role models and mentorship for female medical students considering their career options is critical for enhancing female representation in urology. (3/n)
Read 7 tweets
@LiangGQu, Vaisnavi Thirugnanasundralingam, @damien_bolton, @UroOncMD & @lawrentschuk reviewed the role of tissue-based immunohistochemical markers for diagnosis and classification of #RCC in this 1st edition of #SIUJ!
#OpenAccess #UroSoMe

siuj.org/index.php/siuj…

1/n Image
#RCC presents various subtypes, classified according to anatomical, morphological, immunohistochemical (#IHC) & molecular features. Even after '16 reclassification, tissue biomarkers differentiate RCC subtypes & distinguish them from non-renal neoplasms or metastatic disease
2/n Image
Despite advances in #IHC staining, challenges are:
- Staining heterogeneity across and within tumors
- Variations in processing may = inconsistencies
- Revisions by @WHO & @ISUPorg = misinterpretation of older literature
- Smaller samples (biopsies) needing to be analyzed

3/n
Read 7 tweets
In the first issue of #SIUJ, @AnkeetShahMD @DominicGrimberg @BrantInman discussed the classification of molecular biomarkers. #OpenAccess siuj.org/index.php/siuj… (1/n)
A “biomarker” is any measurable characteristic that indicates the presence or absence of disease or the biological response to a stimulus, typically an exposure or intervention. (2/n)
The FDA-NIH Biomarker Working Group has produced a document called Biomarkers, EndpointS and other Tools (BEST), which defines 7 categories of biomarkers according to their clinical usage. (3/n)
Read 9 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!